Member Info for extrader

I'm sure there's lots going on at a low key level on the covid front - I'm in a head-to-head trial of Moderna's existing Spikevax booster against 1 of 2 Omicron-tweaked variants.

And I and my cohort aren't members of Club 18-30, either....

PS I'd wait until your friend shows you her own documented purchase, btw.
Someone may be playing you.

Why share your inside tip with the board ...and risk having to pony up more when you do eventually decide to buy in ?
You're kind of 'front running' against yourself... !

AFAICS.

If there's a placing (which is what the Venus Capital proposal is) that increases SYME's sharebase from, say, 40 billion to 50 billion ie a 25% increase, unless you as PI's also increase your existing holding by 25% , you will have a smaller relative and absolute share of the SYME pie.
If your 25% increase is by participating in the Open Offer, the cash you pay will benefit SYME. If you top up 25% in the market, the cash you pay will go to the seller.

One interesting question is whether the Open Offer to PI's will happen AT THE SAME TIME as the subscription to Venus Capital's mandatory tranches...or only ON THE SAME TERMS .

Another is that PI's will presumably have to be invited via a formal, 'content-rich' Placing Prospectus.

AFAICS

“I'm excited to partner with Venus Capital and its powerful eco-system of long-term investors”

AZ was excited about the British HNWI's (remember them ?) and the 5 New Investors RNS'd 24 Dec 2020.

That was just shares changing hands (TAG offloading 4 billion), the Venus Capital proposal is a placing / disguised rights issue , where the proceeds will actually flow to SYME itself.....

You can see why, wearing his CEO hat, AZ would be excited by this.
AFAICS

Hi nomlungu,

Thanks for the link to Venus Capital s.a. https://www.northdata.com/Venus+Capital+SA,+Luxembourg/B244639

Others have pointed to its recent startup (May 2020) and minimal capital (Euro 31K) as grounds for questioning its ability/willingness to be a longterm , substantial equity investor in SYME.

It's also worth looking at the Board and its main director, shown as Andrea La. This is Andrea La Magra, b May 1980.

Click on his icon and this takes you to northdata showing him as director of 17 companies in various jurisdictions, mostly in a tax consultancy capacity, see https://www.companydirectorcheck.com/andrea-la-magra-2.# and https://www.linkedin.com/in/andrea-la-magra-55894354/?originalSubdomain=mc.

Perhaps not surprisingly, his link https://www.datocapital.lu/executives/Andrea-La-Magra.html says that
- Andrea La Magra has also appointments in companies of United Kingdom
- Andrea La Magra has also appointments in companies of Panama
- Andrea La Magra has also appointments in companies of Malta.
And linkedin also has him as owner and director of Vera Consulting in Monaco, whose activities per its articles include :

.."In the Principality of Monaco and abroad, for all natural or legal persons, in the fields of private equity, mergers and acquisitions and corporate restructuring: all study and analysis services enabling the structuring and implementation of economic projects as well as the search for and identification of potential targets, to the exclusion of all regulated activities and in particular those covered by law n° 1.338 of 7 September 2007 on financial activities..."

I wonder if La Magra is the so-far unnamed new advisor to SYME ?

(I'm channelling apunter2 a bit here, with this speculation.....)

Ho hum.

..".”To date, Supply@ME has run two pilot projects with banks in Italy, monetising €550m worth of inventory across two businesses. First, it monitized €250m worth of inventory for an Italian electronic retailer and then it financed €300m of livestock – “literally live stock,” grins Zamboni – for an agricultural owner..."

Would some kind person/apologist for AZ pls explain why these deals are never referenced when discussing IM and proof of concept and - 2-4 years 'after the event' - we still know nothing about them ?

TIA

SPC has been delisted and only trades via Jarvis Securities on a matched bargain basis.
The company, per exchange reported on ticker SPC, seems to think it will eventually get FCA approval.
The new Long Stop date is 27 May 2022.
See https://www.investegate.co.uk/u.k.-spac-plc/rns/letter-to-shareholders-of-u.k.-spac-plc/202204080700046990H/

HTH, NAI, GLA etc, etc....

.."hope we haven't been duped and maybe there are no shares?.."

A comment like this doesn't exactly help your credibility, in my book.

.."If you don’t believe the derampers get paid by companies to **** your investment off!! Here’s some proof that it goes on!.."

Thanks for this snippet.
But, but , but.......(a) your comment refers explicitly to Telegram...and (b) Telegram appears to be the source of mostly BULLISH comment re SYME.

Looks to me like you've made a good case for the existence of RAMPING , if anything !

;->

To clarify, Buffett's recent buys are roughly a trebling of BH's exposure to the oil sector.

From the ECO board, hat-tip to davwal

A strong signal regarding oil from the master investor, which won’t do the wider industry any harm -
Mail Online:
“The business magnate also allocated $7 billion toward shares of Occidental Petroleum in the first half of March, grabbing 14 percent of the oil producer's total shares.
He also revealed that he boosted Berkshire's stake in oil giant Chevron to $26 billion, up from $4.5 billion at the beginning of the year, making it one of the conglomerate's largest four investments.”

Up to now, Buffett has tended to be more a 'supplier of picks and shovels' than a 'gold-miner' : his major owned investment BSNF Rail (bought for $ 34 Bn in 2009) is a major transporter of coal and oil across the US.

Putting $ 28.5 Bn [7 + (26-4.5)] into producers recently is quite a shift. US News puts Berkshire Hathaways' total current investment in oil producers at $ 40 billion, ie a trebling of exposure to the sector.

'May the trend be our friend'.

Thanks beardozer.

There are a lot of possible permutations here, ranging from 'worst case' outright expropriation (without compensation)- unlikely IMO - through to 'full mine development' , by GLEN/ZIOC as originally envisaged in the IPO - equally unlikely, IMO, esp. given GLEN's known aversion to greenfield projects.
In between , you've got a cheap sale to a likely Chinese buyer (see 'monopsony', the opposite of 'monopoly'), where GLEN isn't able to get the side-benefit of a preferential deal for its ore trading arm ; to one where it IS (and doesn't cut ZIOC in in some way); to one where it IS and does; to a deal GLEN cuts with, say Fortescue Metals (Australian miner) that (a) doesn't (b) does include ZIOC in some way. There are AIUI 'tag-along' rights that - depending on how GLEN played things - could potentially be worth a lot......or nothing.....

Over-riding all this is what happens to (a) the global economy , (b) China's demand and (c) Simandou as a potential alternative supplier to Australia.

GLEN isn't emotionally or economically 'legacy-invested' (its accidentally-acquired stake in Zanaga is mostly written down), and ZIOC core investors mostly recouped their $ 30m or so seed / venture capital at the time of the IPO.

While I'd be delighted with a £2-3 per ZIOC share outcome, I think a likelihood-weighted outcome is more in the 50-100p range, with a not insignificant chance of total loss.

Happy to be corrected....and open to counter-arguments, positive or negative !

Thanks for this.

Up to now, Buffett has tended to be a 'supplier of picks and shovels', rather than a 'gold-miner' : his BSNF Rail (bought for $ 34 Bn in 2009) is a major transporter of coal and oil across the US.
Putting $ 28Bn [7 + (26-4.5)] into producers today is quite a shift. US News puts Berkshire Hathaways' total current investment in oil producers at $ 40 billion.
'May the trend be our friend'.

PS anybody interested in the genesis of the RTO that spawned SYME may be interested in this earlier ECP (net assets/equity of £ 424K) RNS, in which they set out how they planned to acquire a stake in TAG, which at the time had been professionally valued at Euro 75 million......

https://www.aquis.eu/aquis-stock-exchange/for-investors/announcements?view_news_id=486373

Full marks for creativity !

Enjoy the Bank holiday weekend everybody.

The 2nd largest holding is way off :
"..8.62% Eight Capital Partners Plc 3,128,074,362 £3.1m ..."

Their interim results to 30 June 2021 show their SYME holding (22.5m shares) as follows :
Supply@Me Capital plc Fair value @ 31 Dec 2020 £ 000's : 128 ie 0.57p
Unrealised loss £ 000's : (43)
Fair value @ 30 Jun 2021 £ 000's 85 ie 0.38p

Fair value now, @ 0.08p , would be around £ 18 K.

All set out in https://www.eight.capital/wp-content/uploads/2021/09/29092021-Interim-Results.pdf

Time for a reality check, maybe.
ATB

Investors at top US banks refuse to back climate proposals
Resolutions at Wells Fargo, Bank of America and Citi called for changes to fossil fuel financing policies

APRIL 26, 2022

Probably too late for NCCL, but maybe useful political cover for anyone even remotely considering coal as an option....like HMG ;->
https://inews.co.uk/news/environment/cumbria-councillors-approve-uk-first-coal-mine-explained-676026

.."Cumbria councillors approve UK’s first coal mine in 30 years £160m project near Whitehaven threatens to undermine Government’s plan to reach net zero emissions by mid-century The first new coal mine in the UK in 30 years has just been approved ..."

'Do as I say, not as I do'....

I've got a copy of the Milan filing for newco, fiscal code, VAT and registration number 12340830962.

Founding date 25/3/2022, registration date 1/4/2022.
Limited liability co, paid up capital Euro 10,000, activity : computer programming activities.
AZ is named as sole director, the ownership capital is provided by 'Supply@Me Capital plc Euro 10,000 100%'.

Newco's registered address is Via Giosue Carducci 36, Milan, its 'Operational headquarters' are at Via Festa del Perdono 10.
It has a 'convenience postbox' email address , at supplymetech@legalmail.it.

All seems kosher, as you would expect.

Thank you Nathan.
To put things in context, the professionals acknowledge that the biotech sector has underperformed recently. From today’s Money Morning

……” Remarkable value is appearing in some unexpected places. As Sven Borho, co-manager of the £2bn Worldwide Healthcare Trust (LSE: WWH), says “we have seen the biggest bear market in 30 years in the biotechnology sector.” In the last 12 months or so, the S&P biotechnology index under-performed the S&P 500 by 64%, falling by nearly 50% to the level last seen in mid-2015.

“The healthcare sector now trades on a 20% discount to the S&P 500, the same as in the financial crisis. Every single time it has traded at such a discount has been the very best time to be invested, especially in innovation and growth.” This was not the consequence of the pandemic that we all expected.…”

Ho hum.

..and Louis at IR has helpfully come back with this reassurance :

.."Open Orphan is cognisant of the situation regarding Arden’s nomad status and will provide an update regarding its new nomad via RNS in due course..."